February 25, 2026 - ChartAlert®

BBOX – Q3 FY26 Earnings Call – 12-Feb-26

BBOX’s FY26 growth slows to 8–10% on execution risks, with FY27 rebound tied to supply chain recovery and $300–350M orders. Margins hold at 9–10% EBITDA, with upside to 10%+ hinging on annuity mix shift, inorganic accretion, and charge abatement.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Supply chain normalizes by H2 FY27, enabling $800M backlog conversion at 80% rate. 2S delivers INR45 crore EBITDA; enterprise revenue grows 12–15%. Outcome: FY27 revenue INR7,200 crore (13% YoY); EBITDA margins expand to 9.5%. Trigger: Stable hyperscaler demand and successful Brazil cross-selling.

FINCABLES – Q3 FY26 Earnings Call – 12-Feb-26

FINCABLES’ topline growth hinges on solar/fiber structural demand and government program execution, while margins face cyclical copper risks and structural competition—expect 11–12% EBIT as the new normal. Bottomline resilience depends on cash flow discipline and auto/solar capacity utilization.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: Copper stabilizes at 13,500 INR, fiber demand sustains, gradual Birla ramp-up.

Topline: 15–18% YoY growth driven by solar/fiber; OFC revenue hits INR 500–600 crore.
Margins: 11–12% EBIT as auto/solar volumes offset wire compression.
Cash Flow: FCF INR 200–250 crore, supporting reinvestment in E-Beam/auto capacity.

AMBER – Q3 FY26 Earnings Call – 10-Feb-26

AMBER’s topline resilience (13–15% Consumer Durables, 79% Electronics growth) and margin expansion (Electronics double-digit FY27) hinge on execution of INR 6,800 Cr capex pipeline and commodity pass-through, with structural risks skewed to integration delays and cyclical RAC demand.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: RAC industry flattish (Amber +13–15%) + Unitronics synergies materialize (H2’27) + KCC/Hosur on schedule.
Outcome: 25–30% consolidated revenue growth, Electronics EBITDA 10–12%, Sidwal +40% YoY. Margins expand 50–100 bps on pass-through and volume leverage.

TORNTPHARM – Q3 FY26 Earnings Call – 13-Feb-26

TORNTPHARM’s base case projects 12–14% CAGR driven by Brazil/U.S. execution and JB integration, with margins expanding to 33–34% by FY29. Outcomes hinge on GLP-1 timing, Germany resolution, synergy capture, and cost discipline, as structural tailwinds offset cyclical pricing pressures

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: (1) Ozempic launches in Brazil by late FY27; (2) JB synergies realize as guided (INR 400–450Cr by FY29).
Outcome: Brazil grows at 12–15% CAGR (ex-Semaglutide); U.S. hits $200M revenue by FY27 (20% CAGR). JB’s margin improves to 30% by FY28. Germany stabilizes by Q2 FY27; alternate supplier onboarded in 3 quarters.
Implications: Topline grows at 12–14% CAGR; EBITDA margins expand to 33–34% by FY29. Net debt/EBITDA targets achieved; interest expense declines to INR ~50Cr by FY29. FCF turns positive by FY28.

VBL (Varun Beverages) – Q3 FY26 Earnings Call – 3-Feb-26

VBL’s topline hinges on weather normalization and Twizza execution, with 10–15% growth probable; bottomline leverages operating scale and cost absorption, targeting 12–20% EPS upside; margins face cyclical realization pressure but structural backward integration supports 23–26% India EBITDA and 17–20% ex-India EBITDA by 2027.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: Normal weather, Twizza synergies on track, snacks scale to ₹500cr.
Outcome: Volumes grow 10–12%; realization improves 2–3% on mix. India EBITDA margins sustain at 24–25%; ex-India margins expand to 17–18%. Free cash flow funds Twizza and brewery; dividend hike likely. Topline: +10–12%; Bottomline: +12–15%.

MOTHERSON – Q3 FY26 Earnings Call – 10-Feb-26

Motherson FY27 outlook: Revenue growth (8–15%) depends on Greenfield execution and European OEM strength; consumer electronics/aerospace scalability is pivotal. EBITDA margins may swing 50–200 bps from commodity/FX, but efficiencies and ROCE discipline cushion downside. Non-auto expansion (40%+ ROCE) offsets auto cyclicality if execution succeeds.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: (1) European OEMs stabilize market share; (2) Greenfields contribute 70% of targeted FY27 revenue; (3) consumer electronics/aerospace scale to 20M units/year by FY28.
Outcome: Revenue grows 10–12% YoY in FY27; EBITDA margins expand 50–100 bps on operational efficiencies and FX tailwinds. Leverage remains 1.0–1.2x; ROCE in new ventures hits 35–40%. Implication: Sustainable topline growth; margin expansion offsets cyclical pressures.